RecruitingNCT06642181
Guanfacine and mindfulness added to buprenorphine treatment
About this title
Read the official source — NCT06642181Medication studyAges 18–55United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- NewarkSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 15, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 224
- Sponsor
- Rutgers, The State University of New Jersey
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT06642181
- Official title
Show the full official title
Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Newark
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Rutgers, The State University of New Jersey, a university.
Does this study involve medication?
Yes. The study involves medication, including Guanfacine pharmacotherapy.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
